- cafead   Sep 16, 2021 at 11:12: PM
via The FDA revised its emergency use authorization for Eli Lilly's COVID-19 antibody cocktail Sept. 16, allowing the treatment to be used as a post-exposure prophylaxis for COVID-19 in individuals who are at high risk for progression to severe COVID-19.
article source
article source